The results showed that overexpression of BCYRN1 was associated with age (≥60 vs.<60, OR = 1.12, 95% CI 0.82–1.15, p=0.475; Figure 3(a)), gender (male vs. female, OR = 0.89, 95% CI 0.63–1.24, p=0.568; Figure 3(b)), tumor size (large vs. small, OR = 1.61, 95% CI 0.82–3.15, p=0.166; Figure 3(c)), lymph node metastasis (positive vs. negative, OR = 2.09, 95% CI 0.79–5.51, p=0.135; Figure 3(d)), and tumor differentiation (poor vs. good, OR = 1.10, 95% CI 0.59–2.05, p=0.774; Figure 3(e)) that were not significantly associated, and the results were not found to be statistically significant. The gene discussed is BCYRN1; the disease is neoplasm.